- All
- Featured news
- News
11May2022
Innovation transforming oligonucleotide manufacturing
Bachem set up unique, innovative equipment that optimizes capacity, delivers high-quality products a...
05May2022
Bachem Earns Gold Medal Sustainability Rating from EcoVadis
Bachem received a gold medal rating for sustainability by EcoVadis, an independent leading global pr...
27Apr2022
Bachem Annual General Meeting 2022
The Annual General Meeting (AGM) 2022 has approved all proposals of the Board of Directors...
26Apr2022
Bachem enters strategic collaboration with Lilly to manufacture oligonucleotide-based drug substances
The annual order volume has the potential to achieve around CHF 100 million....
01Apr2022
A passion for shaping the future of Bachem: Interview with Diana Rinderle
Diana Rinderle, Site Communications Lead Bachem Bubendorf (CH), spoke with us recently about her exp...
29Mar2022
Bachem’s new facilities for large-scale oligonucleotide manufacturing
Bachem built facilities and implemented new, innovative solutions for large-scale oligonucleotide AP...
Careers
At Bachem, we believe that our employees make the difference. Representing our corporate culture of passion and commitment, they are the foundation of our success. We therefore strive to attract, retain, and develop highly motivated, well-qualified individuals.
View all jobs
Click here >>
Contact
We look forward to partnering with you to build up your project development plan for CMC development according to your unique needs.
No matter what stage your NCE is in – pre-IND, early or late clinical stages, or already on the market – contact us to find out what we can do for you.